Literature DB >> 12139669

Steroid responsive cutaneous Rosai-Dorfman disease associated with uveitis and hypothyroidism.

A Salim1, M Williamson, F Barker, J Hughes.   

Abstract

We report a patient with steroid responsive cutaneous Rosai-Dorfman disease (RDD) associated with bilateral anterior uveitis and hypothyroidism. RDD is a rare histiocytic disorder of unknown aetiology. There is characteristic histology in which large pale-staining histiocytes exhibit emperipolesis and stain positive for S-100 protein. This condition is thought to be a reactive process rather than a neoplastic one and viral and immune mediated causes have been postulated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12139669     DOI: 10.1046/j.1365-2230.2002.01020.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

Review 1.  Bilateral anterior granulomatous uveitis associated with cutaneous Rosai-Dorfman disease.

Authors:  Juan G Gaviria; Daniel A Johnson; Marsha C Kinney; Liana H Proffer; Jacqueline M Losi-Sasaki; Eric W Kraus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-09-30       Impact factor: 3.117

2.  Extranodal Rosai-Dorfman of the Pancreas Presents with Bilateral Granulomatous Anterior Uveitis.

Authors:  A'sha Brown; Sara V Branson; Ghazala A Datoo O'Keefe
Journal:  Ocul Oncol Pathol       Date:  2018-10-25

3.  Extranodal rosai-dorfman disease with cutaneous and periodontal involvement: a rare presentation.

Authors:  M J Molina-Garrido; C Guillén-Ponce
Journal:  Case Rep Oncol       Date:  2011-02-16

4.  Cutaneous Rosai-Dorfman Disease Confused with Vascular Mass.

Authors:  Kwang Rae Kang; Sung Won Jung; Sung Hoon Koh
Journal:  Arch Craniofac Surg       Date:  2016-03-21

5.  Rosai-Dorfman disease: a report of eight cases in a tertiary care center and a review of the literature.

Authors:  R C Maia; E de Meis; S Romano; J A Dobbin; C E Klumb
Journal:  Braz J Med Biol Res       Date:  2014-10-10       Impact factor: 2.590

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.